ArticleChild's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery2013

Somatostatin receptor subtype 2 (sst₂) is a potential prognostic marker and a therapeutic target in medulloblastoma.

Marc Remke et al.PubMed ↗Publisher ↗

No numbers read from the abstract.